Fujihara K, Isobe N, Miyamoto K, Niino M, et al. Long-term effectiveness and safety of satralizumab for neuromyelitis optica spectrum disorder in a real-world clinical setting in Japan: A 2.5-year final analysis of a multicenter medical chart review (The SAkuraBeyond Study). Mult Scler 2026;32:302-314.
PMID: 41732099